rfk tirzepatide Tops Semaglutide for Weight Loss in Head-to-Head Trial, Eli Lilly Says Tirzepatide Wins FDA Approval for

The side effect profiles are different in character CagriSema may produce more satiety-related GI effects from dual gastric slowing, while retatrutide may produce more metabolic effects from glucagon-driven thermogenesis but both are generally well-tolerated within their clinical programs

In general, avoid combining Adderall and phentermine

Rees TA, Buttle BJ, Tasma Z, Yang SH, Harris PWR, Walker CS

The researchers reported improvement in more than 80% of the patients, but there was no control group

Lifestyle Factors Are Working Against the Medication GLP-1 medications are powerful tools, but theyre not magic pills